News
Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...
EU approves expanded use of ABBV's Rinvoq and AZN's Imfinzi and Enhertu. NVS set to invest $23B to boost U.S. manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback